Skip to content

Can Telephone Support Help People Who Use Chewing Tobacco to Quit? Evidence from Odisha

Effectiveness of National Tobacco Quitline Services (NTQLS) in cessation among smokeless tobacco (SLT) users: A randomised controlled trial in Tertiary care Hospital, Odisha - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109234
Enrollment
264
Registered
2026-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: BEHAVIOURAL COUNSELLING: Participants will be given a brief advice on harmful effect of tobacco and enrolled in the National Tobacco Quitline Services (NTQLS) through the designated tol

Sponsors

Dr SATYAPRABHA ROUT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of all age groups referred to TCC of SCB Dental College and Hospital, Cuttack will be included in the study. 2.Individuals who are current users of smokeless tobacco products (such as gutkha, khaini, pan masala with tobacco, snuff, or other forms). 3.Individuals who are willing to quit smokeless tobacco. 4.Individuals willing to participate in the cessation intervention.

Exclusion criteria

Exclusion criteria: 1.Individuals who consume or use smoked tobacco products only (cigarettes/bidis) without smokeless tobacco use. 2.Individuals who are currently enrolled in any other tobacco cessation program or clinical trial. 3.Individuals receiving pharmacotherapy for tobacco cessation (nicotine replacement therapy, bupropion, varenicline, or other medications) at the time of recruitment. 4.Individuals with serious medical illnesses or unstable systemic conditions that may interfere with participation or follow-up (e.g., severe cardiac disease, uncontrolled diabetes, or malignancy). 5.Individuals with psychiatric disorders or cognitive impairment that limit their ability to provide reliable information or informed consent. 6.Individuals who are not willing to provide informed consent or unable to comply with the study protocol and scheduled follow-up visits. 7.Participants who plan to relocate or are unlikely to be available for the 24-week follow-up period

Design outcomes

Primary

MeasureTime frame
Point prevalence abstinence from smokeless tobacco use at 4,8,12,24 weeksTimepoint: 4,8,12,24 weeks

Secondary

MeasureTime frame
1.Prolonged abstinence (continuous cessation) over a period of 24 weeks 2.Number and frequency of quit attempts 3.Proportion of participants with relapse 4.Salivary cotinine level assessment at the end of 24 weeks. Timepoint: 6 MONTHS

Countries

India

Contacts

Public ContactDr HEMAMALINI RATH

SCB DENTAL COLLEGE AND HOSPITAL,CUTTACK,ODISHA, Odisha

utkalcommunity@gmail.com9437953285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026